31 Aug 2021

Series C fundraising of Doctor Anywhere

Partners Tracy Ang and Lee Jin Rui from Rajah & Tann Singapore advised Doctor Anywhere, a regional tech-led healthcare company, in its US$65.7 million Series C fundraising round led by Asia Partners, with investors including Novo Holdings, Philips, OSK-SBI Venture Partners, and other existing investors.

28 Aug 2021

S$45.9 Million subscription of shares in BRC Asia Limited and S$22.2 million acquisition of shares in BRC Asia Limited

Partners Danny Lim and Penelope Loh from Rajah & Tann Singapore are advising BRC Asia Limited (“BRC Asia”), which is listed on the Main Board of the Singapore Exchange Securities Trading Limited, in its S$45.9 million placement of new shares to Hong Leong Asia Investments Pte. Ltd. (“Hong Leong Asia”). The firm is also advising Xinsteel Singapore Pte. Ltd., Nuocheng International Trading & Investment Pte. Ltd., Toe Teow Heng, Wu Ai Ping and Shi Yong as vendors in the S$22.2 million sale of shares in BRC Asia to Hong Leong Asia.

24 Aug 2021

S$4.5 million Tokenised Offering of 6% Exchangeable Notes on ADDX

Partners Danny Lim and Tan Mui Hui from Rajah & Tann Singapore are acting for XM Studios Pte. Ltd. in its S$4.5 million tokenised offering of 6% exchangeable notes issued by its parent company, XM Holdco Pte. Ltd., on ADDX, a platform to enable private market investing in unicorns, pre-IPO companies, hedge funds, and other opportunities.

12 Aug 2021

S$204.3 million Private Placement by Keppel DC REIT

Partner Raymond Tong from Rajah & Tann Singapore acted for Citigroup Global Markets Singapore Pte. Ltd., DBS Bank Ltd., Oversea-Chinese Banking Corporation Limited and Credit Suisse (Singapore) Limited, the joint bookrunners and underwriters, in respect of the private placement of new units in Keppel DC REIT to raise gross proceeds of approximately S$204.3 million.